Blogs

What’s your game? Most of the businesses are becoming global and technology-driven, companies everywhere are

Commercial success of pharmaceutical products is subject to several risks, like reliance on third parties,

Dec 4th, 2020, in Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a

On Nov. 30, 2020, the US District Court for the District of Delaware on remand

Nov 2020, the European Commission (EC) has fined Teva and its now subsidiary Cephalon 60.5

The Biologics Price Competition and Innovation Act of 2009 (BPCI Act) established a framework for

Most of the companies obtain an agreement from employee to assign any patents developed while

The introduction of modified versions of original products, is used as a strategy by pharmaceutical

Focus of generic pharmaceutical company is mainly on navigating the innovator’s intellectual property and not